We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$95.4B
1-Year Est. Return
38.74%
This Fund
S&P 500
This Quarter
Est. Return
+5.75%
1 Year Est. Return
+38.74%
3 Year Est. Return
+101.74%
5 Year Est. Return
+133.96%
10 Year Est. Return
+765.1%
AUM
$79.7B
AUM Growth
-$3.54B
(-4.3%)
Cap. Flow
-$8.19B
Cap. Flow
% of AUM
-10.28%
Top 10 Holdings %
Top 10 Hldgs %
14.16%
Holding
2,085
New
185
Increased
629
Reduced
928
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$392M |
| 2 |
Verizon
VZ
|
+$361M |
| 3 |
Occidental Petroleum
OXY
|
+$354M |
| 4 |
Walt Disney
DIS
|
+$162M |
| 5 |
MON
Monsanto Co
MON
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$4.92B |
| 2 |
AstraZeneca
AZN
|
+$621M |
| 3 |
SLM Corp
SLM
|
+$355M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$290M |
| 5 |
SPLS
Staples Inc
SPLS
|
+$278M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.37% |
| 2 | Technology | 14.88% |
| 3 | Healthcare | 12.02% |
| 4 | Industrials | 10.74% |
| 5 | Energy | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPLN
751
Openlane
OPLN
$4.69B
| $9.45M | 0.01% |
+783,142
| New | +$9.05M |
|
752
Ashland
ASH
$3.28B
| $9.43M | 0.01% |
177,331
+148,122
| +507% | +$7.39M |
|
|
GEVA
753
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $9.41M | 0.01% |
+89,780
| New | +$7.64M |
|
|
SYNT
754
DELISTED
Syntel Inc
SYNT
| $9.39M | 0.01% |
218,542
-5,346
| -2% | -$220K |
|
755
Vanguard S&P 500 ETF
VOO
$1.01T
| $9.38M | 0.01% |
52,300
-5,000
| -9% | -$871K |
|
756
Carlyle Group
CG
$17.9B
| $9.37M | 0.01% |
275,800
-24,385
| -8% | -$802K |
|
|
ANFI
757
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $9.29M | 0.01% |
678,497
+219,479
| +48% | +$3.3M |
|
758
Park-Ohio Holdings
PKOH
$599M
| $9.25M | 0.01% |
159,159
+39,423
| +33% | +$2.23M |
|
759
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
| $9.22M | 0.01% |
80,000
+58,600
| +274% | +$6.65M |
|
760
Enovis
ENOV
$1.74B
| $9.12M | 0.01% |
71,100
-16,585
| -19% | -$2.07M |
|
761
HCI Group
HCI
$2.28B
| $9.02M | 0.01% |
222,090
-4,328
| -2% | -$167K |
|
|
762
Bank of America Series L
BAC.PRL
$3.99B
| $8.98M | 0.01% |
7,698
-4,220,656
| -100% | -$4.92B |
|
763
BOK Financial
BOKF
$8.78B
| $8.96M | 0.01% |
134,580
-520
| -0.4% | -$34K |
|
764
Crown Castle
CCI
$32.3B
| $8.96M | 0.01% |
120,688
-37,897
| -24% | -$2.84M |
|
765
Brown & Brown
BRO
$23.7B
| $8.94M | 0.01% |
581,878
+118,982
| +26% | +$1.79M |
|
766
Huntington Ingalls Industries
HII
$12.5B
| $8.91M | 0.01% |
94,215
-50,359
| -35% | -$5.03M |
|
|
FTR
767
DELISTED
Frontier Communications Corp.
FTR
| $8.88M | 0.01% |
101,422
+77,116
| +317% | +$6.67M |
|
768
Edgewell Personal Care
EPC
$1.35B
| $8.88M | 0.01% |
98,187
-13,904
| -12% | -$1.14M |
|
769
Armstrong World Industries
AWI
$7.86B
| $8.8M | 0.01% |
153,275
-22,345
| -13% | -$1.21M |
|
|
ISEE
770
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.75M | 0.01% |
+206,715
| New | +$7.58M |
|
|
CKEC
771
DELISTED
Carmike Cinemas Inc
CKEC
| $8.7M | 0.01% |
247,526
-7,089
| -3% | -$230K |
|
772
Avient
AVNT
$3.48B
| $8.69M | 0.01% |
206,313
-26,616
| -11% | -$1.04M |
|
773
Puma Biotechnology
PBYI
$397M
| $8.69M | 0.01% |
+131,595
| New | +$9.36M |
|
|
TRQ
774
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $8.66M | 0.01% |
259,335
-48,117
| -16% | -$1.78M |
|
775
Woodward
WWD
$22B
| $8.64M | 0.01% |
172,120
-25,511
| -13% | -$1.16M |
|
Similar funds
Allianz Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Allianz Asset Management held 2,085 positions worth $79.7B, down 4.3% from $83.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Allianz Asset Management withdrew a net $8.19B in Q2 2014, closing 145 positions and reducing 928 holdings. Its most notable exit was Pentair, an estimated $54.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Allianz Asset Management opened a new position in GSK worth $387M.
- Allianz Asset Management's largest Q2 2014 buy was GSK: 5,790,408 shares worth $387M.
- Allianz Asset Management added most to Verizon in Q2 2014, an estimated $361M increase.
- Allianz Asset Management's biggest Q2 2014 reduction was Bank of America Series L, cutting an estimated $4.92B.
- Allianz Asset Management fully exited Pentair in Q2 2014, selling an estimated $54.1M.
- Allianz Asset Management's ten largest holdings make up 14% of its $79.7B portfolio in Q2 2014.
- Allianz Asset Management opened 185 new positions and closed 145 in Q2 2014.
- Allianz Asset Management's portfolio value fell 4.3% quarter-over-quarter to $79.7B.
Based on Allianz Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.